echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Johnson & Johnson Orthokeratology Contact Lenses Received FDA Approval Today

    Johnson & Johnson Orthokeratology Contact Lenses Received FDA Approval Today

    • Last Update: 2021-05-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Today, Johnson & Johnson Vision, a subsidiary of Johnson & Johnson, announced that the US FDA has approved the company’s ACUVUE Abiliti therapeutic contact lens to be marketed.


    Myopia is a progressive chronic eye disease.


    Myopia does not only affect vision.


    Orthokeratology contact lenses are contact lenses that are individually designed for the shape of the patient's cornea.


    ACUVUE Abiliti is a orthokeratology contact lens for patients to wear at night, and does not need to be worn during the day.


    Note: The original text has been deleted

    Reference materials:

    [1] Johnson & Johnson Vision Announces FDA Approval ofACUVUE® Abiliti™ Overnight Therapeutic Lenses for Myopia Management.


    [2] Baird et al.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.